| Dr Donald T Mcknight, MD | |
|
28 Medical Center Dr, Jackson, TN 38301-3947 | |
| (731) 427-9971 | |
| (731) 424-2052 |
| Full Name | Dr Donald T Mcknight |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 37 Years |
| Location | 28 Medical Center Dr, Jackson, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225011588 | NPI | - | NPPES |
| 0139531 | Other | TN | BLUE CROSS BLUE SHIELD |
| 04476611 | Other | TN | AETNA |
| 3067599 | Medicaid | TN | |
| 3496966 | Other | TN | CIGNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD0000023490 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jackson-madison County General Hospital | Jackson, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jackson Urological Associates, P.c. | 5395728935 | 6 |
News Archive
The work follows a study carried out by Oregon Health and Science University, which suggested a link between a gene mutation in mice and tolerance to alcohol. Researchers at Liverpool have investigated this in worms, looking specifically at the role the gene plays in communication between cells in the nervous system.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
How long your parents lived does not affect how long you will live. Instead it is how you live your life that determines how old you will get, reveals research from the University of Gothenburg recently published in the Journal of Internal Medicine.
Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.
› Verified 2 days ago
| Entity Name | Jackson Urological Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770566986 PECOS PAC ID: 5395728935 Enrollment ID: O20040612000367 |
News Archive
The work follows a study carried out by Oregon Health and Science University, which suggested a link between a gene mutation in mice and tolerance to alcohol. Researchers at Liverpool have investigated this in worms, looking specifically at the role the gene plays in communication between cells in the nervous system.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
How long your parents lived does not affect how long you will live. Instead it is how you live your life that determines how old you will get, reveals research from the University of Gothenburg recently published in the Journal of Internal Medicine.
Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald T Mcknight, MD Po Box 1446, Dyersburg, TN 38025-1446 Ph: (731) 427-9971 | Dr Donald T Mcknight, MD 28 Medical Center Dr, Jackson, TN 38301-3947 Ph: (731) 427-9971 |
News Archive
The work follows a study carried out by Oregon Health and Science University, which suggested a link between a gene mutation in mice and tolerance to alcohol. Researchers at Liverpool have investigated this in worms, looking specifically at the role the gene plays in communication between cells in the nervous system.
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
How long your parents lived does not affect how long you will live. Instead it is how you live your life that determines how old you will get, reveals research from the University of Gothenburg recently published in the Journal of Internal Medicine.
Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.
› Verified 2 days ago
Dr. Peter G Lawrence, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 28 Medical Center Dr, Jackson, TN 38301 Phone: 731-427-9971 Fax: 731-424-2052 | |
John L Shaw Jr., MD Urology Medicare: Not Enrolled in Medicare Practice Location: 379 Hospital Blvd, Jackson, TN 38305 Phone: 731-240-1777 Fax: 731-427-9973 | |
James R Appleton Jr., MD Urology Medicare: Medicare Enrolled Practice Location: 616 W Forest Ave, Jackson, TN 38301 Phone: 731-422-0292 Fax: 731-422-0402 | |
Dr. David G. Burleson, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 28 Medical Center Dr, Jackson, TN 38301 Phone: 731-427-9971 Fax: 731-424-2052 | |
Dr. Raymond C Howard, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 28 Medical Center Dr, Jackson, TN 38301 Phone: 731-427-9971 Fax: 731-424-2052 | |
Dr. John B Carraher, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 28 Medical Center Dr, Jackson, TN 38301 Phone: 731-427-9971 Fax: 731-424-2052 |